OpenVSafe by OpenVAERS
Search V-safe

G2G-24370-12863

2 vaccinations 12 coded responses 14 check-ins 12 free-text entries 3 call cases
Sex
Female
Age at first dose
51-55
ZIP prefix
917 / CA
Registered
2021-03-17
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-02-23
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-16
    Dose 2 — Pfizer-BioNTech
  3. 2021-03-17
    Registered in v-safe
  4. 2021-03-17
    Survey response — days 1–6 daily, dose 2
    MedDRA: Hypopnoea — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities
    Free text: Breathing is shallow
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-03-18
    Survey response — days 1–6 daily, dose 2
    MedDRA: Rhinorrhoea, Sinus congestion — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: Runny nose and sinus congestion
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-03-19
    Survey response — days 1–6 daily, dose 2
    MedDRA: Rhinorrhoea — Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tiredness
    Free text: Severe runny nose
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-03-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Itching · Muscle or body aches, Rash, not including the immediate area around the injection site
    Adult check-in
  8. 2021-03-21
    Survey response — days 1–6 daily, dose 2
    MedDRA: Rhinorrhoea, Sinus disorder — Feeling: Good · Fatigue or tiredness, Rash, not including the immediate area around the injection site
    Free text: Sinus and runny nose
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-03-22
    Survey response — days 1–6 daily, dose 2
    MedDRA: Sinus disorder — Feeling: Good · Rash, not including the immediate area around the injection site
    Free text: Sinus issues remain
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-03-23
    Survey response — day 7, dose 2
    MedDRA: Paranasal sinus hypersecretion — Feeling: Fair · Site: Pain, Itching · Rash, not including the immediate area around the injection site
    Free text: Sinus issues/drainage
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-03-30
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-04-06
    Survey response — day 21, dose 2
    MedDRA: COVID-19, Office visit, Rash — Feeling: Fair · Get care from a doctor or other healthcare professional
    Free text: Symptoms: My rashes that started with COVID continue.I now have to use steroid cream. · Healthcare visit (other): Office visit
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-04-06
    Report sent to call center — day 21, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  14. 2021-04-13
    Survey response — day 28, dose 2
    MedDRA: Office visit, Rash, Self-medication, Sinus disorder — Feeling: Good · Get care from a doctor or other healthcare professional · Hospitalization
    Free text: Symptoms: My immune system is still fighting hard. Im still experiencing skin rashes and sinus issues. Quite severe to the point where Im now using steroid cream for the skin issues and daily decongestant and antihistamines. · Healthcare visit (other): Office visit
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-04-13
    Report sent to call center — day 28, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  16. 2021-04-21
    Survey response — day 35, dose 2
    MedDRA: Rash — Feeling: Good
    Free text: Rash continues
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-04-27
    Survey response — day 42, dose 2
    MedDRA: Rash — Feeling: Good
    Free text: Skin rashes continue unabated.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-06-15
    Survey response — 3 months, dose 2
    MedDRA: Arthralgia, Joint swelling, Pain in extremity, Peripheral swelling, Skin discomfort, Skin disorder — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Swollen ankles and fingers. Fingers hurt.Skin issues continue.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-11-06
  20. 2022-03-16
    Survey response — 12 months, dose 2
    MedDRA: COVID-19, Rash, Skin irritation — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Skin rashes and irritation flare up. This condition started when I had Covid-19 and I have never fully recovered.
    MedDRA releases: 2024-11 · check-in free text available
  21. 2022-03-16
    Report sent to call center — 12 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  22. 2022-03-17

Vaccinations

DoseDateManufacturerCo-administered
12021-02-23Pfizer-BioNTech
22021-03-16Pfizer-BioNTech

Call center

3 call center cases

3 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 5 — days 1–6 daily, dose 2

2021-03-17

Systemic reaction (other): Breathing is shallow

2021-03-18

Systemic reaction (other): Runny nose and sinus congestion

Release 6 — days 1–6 daily, dose 2

2021-03-19

Systemic reaction (other): Severe runny nose

2021-03-21

Systemic reaction (other): Sinus and runny nose

2021-03-22

Systemic reaction (other): Sinus issues remain

Release 6 — day 7, dose 2

2021-03-23

Systemic reaction (other): Sinus issues/drainage

Release 7 — day 21, dose 2

2021-04-06

Symptoms: My rashes that started with COVID continue.I now have to use steroid cream.
Healthcare visit (other): Office visit

Release 7 — day 28, dose 2

2021-04-13

Symptoms: My immune system is still fighting hard. Im still experiencing skin rashes and sinus issues. Quite severe to the point where Im now using steroid cream for the skin issues and daily decongestant and antihistamines.
Healthcare visit (other): Office visit

Release 7 — day 35, dose 2

2021-04-21

Symptoms: Rash continues

Release 8 — day 42, dose 2

2021-04-27

Symptoms: Skin rashes continue unabated.

Release 9 — 3 months, dose 2

2021-06-15

Symptoms: Swollen ankles and fingers. Fingers hurt.Skin issues continue.

Release 11 — 12 months, dose 2

2022-03-16

Symptoms: Skin rashes and irritation flare up. This condition started when I had Covid-19 and I have never fully recovered.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit ✓ ✓ ✓
SDArthralgia ✓ ✓ ○
SDCOVID-19 ✓ ✓ ✓
SDJoint swelling ✓ ✓ ✓
SDPain in extremity · · ✓
SDPeripheral swelling ✓ ✓ ✓
SDRash ✓ ✓ ✓
SDSelf-medication ✓ ✓ ✓
SDSinus disorder ✓ ✓ ✓
SDSkin discomfort ✓ ✓ ○
SDSkin disorder · · ✓
SDSkin irritation · · ✓
SROHypopnoea ✓ ✓ ✓
SROParanasal sinus hypersecretion ✓ ✓ ✓
SRORhinorrhoea ✓ ✓ ✓
SROSinus congestion ✓ ✓ ✓
SROSinus disorder ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release